Literature DB >> 27541155

Association between type 1, type 2 cytokines, diabetic autoantibodies and 25-hydroxyvitamin D in children with type 1 diabetes.

I M Talaat1, A Nasr2,3, A A Alsulaimani4, H Alghamdi5, K A Alswat6, D M Almalki5, A Abushouk2, A M Saleh7, G Allam8,9.   

Abstract

PURPOSE: Vitamin D may play a role in the pathogenesis of type 1 diabetes (T1D). The aim of the current study was to determine the possible association between 25-hydroxyvitamin D [25(OH)D] levels and circulating levels of type 1 and type 2 cytokines, as well as the pathophysiology of T1D in children.
METHODS: A total of 250 T1D patients and 250 sex- and age-matched T1D-free controls were screened for 25(OH)D, hemoglobin A1c (HbA1c), type 1 and type 2 cytokines, C-reactive protein (CRP) and bone mineral metabolism, as well as antibodies against insulin, glutamic acid decarboxylase (anti-GAD 65) and islet cells.
RESULTS: Our data showed that the plasma level of 25(OH)D was significantly lower in T1D patients and that there was a significant negative correlation between 25(OH)D levels and HbA1c values. There was a significant association between deficient levels of 25(OH)D and higher levels of cytokines (IFN-γ, TNF-α, IL-6, IL-1β, IL-4 and IL-10) and CRP. Total blood hemoglobin, the hematocrit percentage, body mass index SDS values, phosphate and magnesium levels were significantly lower in T1D patients than in T1D-free subjects. The levels of parathyroid hormone and alkaline phosphatase were significantly higher in T1D patients. Higher levels of cytokines were significantly associated with deficient levels of 25(OH)D. Moreover, in T1D patients, higher levels of islet antibodies, anti-GAD antibodies and anti-insulin antibodies were significantly associated with deficient levels of 25(OH)D.
CONCLUSIONS: In type 1 diabetic children, deficient levels of 25(OH)D are associated with high levels of HbA1c, circulatory cytokines and antibody markers.

Entities:  

Keywords:  Antibodies; Cytokines; Immunomodulation; Pathogenesis; Type 1 diabetes; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 27541155     DOI: 10.1007/s40618-016-0514-9

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  42 in total

1.  Fetal biometry at 4300 m compared to sea level in Peru.

Authors:  E Krampl; C Lees; J M Bland; J Espinoza Dorado; G Moscoso; S Campbell
Journal:  Ultrasound Obstet Gynecol       Date:  2000-07       Impact factor: 7.299

2.  IOM committee members respond to Endocrine Society vitamin D guideline.

Authors:  Clifford J Rosen; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; JoAnn E Manson; Susan T Mayne; A Catharine Ross; Sue A Shapses; Christine L Taylor
Journal:  J Clin Endocrinol Metab       Date:  2012-03-22       Impact factor: 5.958

3.  gamma-Interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses.

Authors:  A S Dusso; S Kamimura; M Gallieni; M Zhong; L Negrea; S Shapiro; E Slatopolsky
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

Review 4.  Breaking down the blood-brain barrier: signaling a path to cerebral malaria?

Authors:  Sue Adams; Heidi Brown; Gareth Turner
Journal:  Trends Parasitol       Date:  2002-08

5.  A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness.

Authors:  Yanbin Dong; Inger S Stallmann-Jorgensen; Norman K Pollock; Ryan A Harris; Daniel Keeton; Ying Huang; Ke Li; Reda Bassali; De-huang Guo; Jeffrey Thomas; Gary L Pierce; Jennifer White; Michael F Holick; Haidong Zhu
Journal:  J Clin Endocrinol Metab       Date:  2010-07-21       Impact factor: 5.958

Review 6.  Intracellular magnesium and insulin resistance.

Authors:  Junji Takaya; Hirohiko Higashino; Yohnosuke Kobayashi
Journal:  Magnes Res       Date:  2004-06       Impact factor: 1.115

7.  The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells.

Authors:  Brett D Mahon; Anja Wittke; Veronika Weaver; Margherita T Cantorna
Journal:  J Cell Biochem       Date:  2003-08-01       Impact factor: 4.429

Review 8.  Cytokine signalling in the beta-cell: a dual role for IFNgamma.

Authors:  Conny Gysemans; Hanne Callewaert; Lutgart Overbergh; Chantal Mathieu
Journal:  Biochem Soc Trans       Date:  2008-06       Impact factor: 5.407

9.  Roles of cytokines in the pathogenesis and therapy of type 1 diabetes.

Authors:  Alex Rabinovitch; Wilma L Suarez-Pinzon
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

Review 10.  Vitamin D and autoimmune diabetes.

Authors:  Julia B Zella; Hector F DeLuca
Journal:  J Cell Biochem       Date:  2003-02-01       Impact factor: 4.429

View more
  10 in total

Review 1.  Immunotherapy for type 1 diabetes.

Authors:  Davide Frumento; Moufida Ben Nasr; Basset El Essawy; Francesca D'Addio; Gian Vincenzo Zuccotti; Paolo Fiorina
Journal:  J Endocrinol Invest       Date:  2017-03-04       Impact factor: 4.256

Review 2.  Heterogeneity and Stability in Foxp3+ Regulatory T Cells.

Authors:  Booki Min
Journal:  J Interferon Cytokine Res       Date:  2017-07-11       Impact factor: 2.607

3.  IL-6 and type 1 diabetes mellitus: T cell responses and increase in IL-6 receptor surface expression.

Authors:  Karina Braga Gomes
Journal:  Ann Transl Med       Date:  2017-01

4.  Influence of vitamin D levels on the cardiovascular profile of hypogonadal men.

Authors:  G Tirabassi; M Cutini; G Salvio; G Cerqueni; A Lenzi; G Balercia
Journal:  J Endocrinol Invest       Date:  2017-04-08       Impact factor: 4.256

Review 5.  The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Yong-Chao Qiao; Yin-Ling Chen; Yan-Hong Pan; Fang Tian; Yan Xu; Xiao-Xi Zhang; Hai-Lu Zhao
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 6.  25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies.

Authors:  Cem Ekmekcioglu; Daniela Haluza; Michael Kundi
Journal:  Int J Environ Res Public Health       Date:  2017-01-28       Impact factor: 3.390

Review 7.  Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.

Authors:  Aikaterini Kountouri; Emmanouil Korakas; Ignatios Ikonomidis; Athanasios Raptis; Nikolaos Tentolouris; George Dimitriadis; Vaia Lambadiari
Journal:  Antioxidants (Basel)       Date:  2021-05-09

8.  Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis.

Authors:  Hans-Klaus Goischke
Journal:  Ther Clin Risk Manag       Date:  2019-07-12       Impact factor: 2.423

Review 9.  Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases.

Authors:  Mattia Bellan; Laura Andreoli; Chiara Mele; Pier Paolo Sainaghi; Cristina Rigamonti; Silvia Piantoni; Carla De Benedittis; Gianluca Aimaretti; Mario Pirisi; Paolo Marzullo
Journal:  Nutrients       Date:  2020-03-17       Impact factor: 5.717

10.  Confirmation and Identification of Biomarkers Implicating Environmental Triggers in the Pathogenesis of Type 1 Diabetes.

Authors:  Robert Z Harms; Katie R Ostlund; Monina S Cabrera; Earline Edwards; Marisa Fisher; Nora Sarvetnick
Journal:  Front Immunol       Date:  2020-09-15       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.